Has Ashlee Bolt received payments from drug or device companies?

Yes. Drug and device makers reported $4,054 in general payments to Ashlee Bolt across 152 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ashlee Bolt did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ashlee Bolt come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ashlee Bolt

Psychiatric/Mental Health · San Diego, CANPI 1669816492

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 29.9% of the total. 2025 is the largest year on record at $1,284, 7.2 times the $178 reported in 2021.

$4,054in general payments, 2019–2025

Across 152 payments — averaging $26.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
Lundbeck LLC$620
Supernus Pharmaceuticals, Inc.$494
Alkermes, Inc.$435
Axsome Therapeutics, Inc.$291
Johnson & Johnson$167
plus $833 from 9 others

What the payments were for

Food & beverage$4,054100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	41	$1,213
Lundbeck LLC	19	$620
Supernus Pharmaceuticals, Inc.	24	$494
Alkermes, Inc.	20	$435
Axsome Therapeutics, Inc.	9	$291
Johnson & Johnson	7	$167
Neurocrine Biosciences, Inc.	5	$146
AbbVie	6	$141
Harmony Biosciences LLC	4	$134
Otsuka America Pharmaceutical, Inc.	5	$133
Vanda Pharmaceuticals Inc.	4	$105
Sunovion Pharmaceuticals Inc.	3	$89
Teva Pharmaceuticals USA, Inc.	2	$39
Idorsia Pharmaceuticals US Inc	2	$33
Indivior Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CAPLYTA$115

How this compares

$4,054 in reported general payments places this provider in the 85th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California →

Other psychiatric/mental health in San Diego

Kelvin PoonSan Diego$16K
Fernando SerranoSan Diego$16K
Rona HausserSan Diego$10K
Carey MartinMillbrae$745K
Liberty MaciasRedlands$288K
Joshua BurgettSacramento$239K
Jovita Ezirim-SalamialofojeLos Angeles$162K
Angie-Kolleen TanThousand Oaks$159K
Thy LamVista$121K
Samantha PerkinsAnaheim$49K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →